C David Pauza
Overview
Explore the profile of C David Pauza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1576
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muvarak N, Li H, Lahusen T, Galvin J, Kumar P, Pauza C, et al.
Front Med (Lausanne)
. 2022 Dec;
9:1044713.
PMID: 36452901
Clinical Trial Registration: www.clinicaltrials.gov, identifier: NCT03215004.
2.
Liou M, Lahusen T, Li H, Xiao L, Pauza C
Front Immunol
. 2022 Oct;
13:1012051.
PMID: 36275712
Human Vγ9Vδ2 T cells are attractive candidates for cancer immunotherapy due to their potent capacity for tumor recognition and cytolysis of many tumor cell types. However, efforts to deploy clinical...
3.
Ochsner S, Li W, Rajendrakumar A, Palaniyandi S, Acharya G, Liu X, et al.
J Immunol
. 2021 Aug;
207(5):1310-1321.
PMID: 34380652
The respiratory tract is constantly exposed to various airborne pathogens. Most vaccines against respiratory infections are designed for the parenteral routes of administration; consequently, they provide relatively minimal protection in...
4.
Pauza C, Huang K, Bordon J
Curr Opin HIV AIDS
. 2021 Feb;
16(2):83-87.
PMID: 33625039
Purpose Of Review: Tremendous advances in cell and gene therapy may soon realize the goal of treating and possibly curing HIV disease. These advances rely on new technologies for cell...
5.
Li H, Lahusen T, Xiao L, Muvarak N, Blazkova J, Chun T, et al.
Mol Ther Methods Clin Dev
. 2020 May;
17:1048-1060.
PMID: 32462053
Activation, infection, and eventual depletion of human immunodeficiency virus (HIV)-specific cluster of differentiation 4 (CD4) T cells are the crucial pathogenetic events in acquired immunodeficiency syndrome (AIDS). We developed a...
6.
Liu X, Palaniyandi S, Zhu I, Tang J, Li W, Wu X, et al.
Nat Commun
. 2019 Jul;
10(1):3020.
PMID: 31289263
Human cytomegalovirus (HCMV) can persistently infect humans, but how HCMV avoids humoral immunity is not clear. The neonatal Fc receptor (FcRn) controls IgG transport from the mother to the fetus...
7.
Pauza C, Liou M, Lahusen T, Xiao L, Lapidus R, Cairo C, et al.
Front Immunol
. 2018 Jun;
9:1305.
PMID: 29937769
Human gamma delta T cells have extraordinary properties including the capacity for tumor cell killing. The major gamma delta T cell subset in human beings is designated Vγ9Vδ2 and is...
8.
Bagchi S, Burrowes S, Fantry L, Hossain M, Tollera G, Kottilil S, et al.
SAGE Open Med
. 2017 Aug;
5:2050312117725644.
PMID: 28839941
Objective: To determine factors associated with increased risk of developing cardiovascular disease in a high-risk patient population. Design: Cross-sectional analysis of a retrospective cohort study. Methods: One-hundred patients at an...
9.
Buonaguro F, Pauza C, Tornesello M, Hainaut P, Franco R, Tommasino M
Biomed Res Int
. 2017 Jul;
2017:7362721.
PMID: 28698877
No abstract available.
10.
Shubin Z, Li W, Poonia B, Ferrari G, LaBranche C, Montefiori D, et al.
Clin Vaccine Immunol
. 2017 Apr;
24(6).
PMID: 28404572
A goal for HIV prevention programs is to develop safe, effective vaccines that elicit durable and broadly protective antibodies. Many vaccine programs focus on the immune responses to critical epitopes...